AUH Stock Overview
Engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
EGF Theramed Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.11 |
| 52 Week High | CA$0.26 |
| 52 Week Low | CA$0.0026 |
| Beta | -2.35 |
| 11 Month Change | 142.52% |
| 3 Month Change | 141.49% |
| 1 Year Change | -29.50% |
| 33 Year Change | -64.97% |
| 5 Year Change | n/a |
| Change since IPO | -86.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| AUH | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -14.3% | 1.2% | 1.3% |
| 1Y | -29.5% | -19.7% | 7.9% |
Return vs Industry: AUH underperformed the German Pharmaceuticals industry which returned -19% over the past year.
Return vs Market: AUH underperformed the German Market which returned 7.2% over the past year.
Price Volatility
| AUH volatility | |
|---|---|
| AUH Average Weekly Movement | 131.3% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: AUH's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: AUH's weekly volatility has increased from 72% to 131% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Connor Yuen | www.egftheramedhealth.com |
EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. The company offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. It also explores other medical areas, including weight loss, skin care, and heart disease.
EGF Theramed Health Corp. Fundamentals Summary
| AUH fundamental statistics | |
|---|---|
| Market cap | €1.96m |
| Earnings (TTM) | -€166.10k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-11.8x
P/E RatioIs AUH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AUH income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$3.11k |
| Gross Profit | -CA$3.10k |
| Other Expenses | CA$242.59k |
| Earnings | -CA$245.70k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.021 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -37.7% |
How did AUH perform over the long term?
See historical performance and comparison